Non Hodgkin Lymphoma Incidence and Mortality by Age group, New York City, 2016-2020
Source: New York State Cancer Registry
Age Group | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
0–4 years | 2.4 | 0.4 | 0.2-0.8 | 1.6 | 0.6 | 0.3-1.2 | 0.8 | 0.3 | 0.1-0.8 | 0.0 | 0.0 | 0.0-0.1 | 0.0 | 0.0 | 0.0-0.3 | 0.0 | 0.0 | 0.0-0.3 |
5–9 years | 7.6 | 1.6 | 1.1-2.1 | 5.6 | 2.3 | 1.5-3.3 | 2.0 | 0.8 | 0.4-1.6 | 0.2 | 0.0 | 0.0-0.2 | 0.2 | 0.1 | 0.0-0.4 | 0.0 | 0.0 | 0.0-0.3 |
10–14 years | 8.6 | 1.9 | 1.4-2.6 | 6.0 | 2.6 | 1.8-3.7 | 2.6 | 1.2 | 0.6-2.0 | 0.4 | 0.1 | 0.0-0.3 | 0.4 | 0.2 | 0.0-0.6 | 0.0 | 0.0 | 0.0-0.3 |
15–19 years | 11.2 | 2.5 | 1.9-3.3 | 6.6 | 3.0 | 2.0-4.1 | 4.6 | 2.1 | 1.3-3.1 | 1.0 | 0.2 | 0.1-0.5 | 0.6 | 0.3 | 0.1-0.8 | 0.4 | 0.2 | 0.0-0.7 |
20–24 years | 21.2 | 4.0 | 3.3-4.8 | 13.0 | 5.1 | 3.9-6.4 | 8.2 | 3.0 | 2.1-4.0 | 2.2 | 0.4 | 0.2-0.7 | 1.8 | 0.7 | 0.3-1.3 | 0.4 | 0.1 | 0.0-0.5 |
25–29 years | 28.2 | 3.7 | 3.1-4.3 | 13.2 | 3.5 | 2.7-4.5 | 15.0 | 3.8 | 3.0-4.7 | 1.6 | 0.2 | 0.1-0.4 | 1.0 | 0.3 | 0.1-0.6 | 0.6 | 0.2 | 0.0-0.4 |
30–34 years | 47.4 | 6.5 | 5.7-7.4 | 26.8 | 7.5 | 6.3-8.9 | 20.6 | 5.6 | 4.6-6.8 | 2.0 | 0.3 | 0.1-0.5 | 1.0 | 0.3 | 0.1-0.7 | 1.0 | 0.3 | 0.1-0.6 |
35–39 years | 53.8 | 8.8 | 7.8-9.9 | 30.6 | 10.3 | 8.7-12.0 | 23.2 | 7.4 | 6.1-8.9 | 5.8 | 0.9 | 0.6-1.4 | 4.4 | 1.5 | 0.9-2.2 | 1.4 | 0.4 | 0.2-0.9 |
40–44 years | 65.8 | 12.4 | 11.1-13.8 | 35.4 | 13.8 | 11.8-16.0 | 30.4 | 11.0 | 9.4-12.9 | 6.2 | 1.2 | 0.8-1.7 | 3.8 | 1.5 | 0.9-2.3 | 2.4 | 0.9 | 0.5-1.5 |
45–49 years | 90.8 | 17.3 | 15.7-19.0 | 48.4 | 19.2 | 16.9-21.8 | 42.4 | 15.5 | 13.5-17.8 | 9.8 | 1.9 | 1.4-2.5 | 6.4 | 2.5 | 1.7-3.6 | 3.4 | 1.2 | 0.7-2.0 |
50–54 years | 130.8 | 24.9 | 23.0-26.8 | 70.4 | 28.1 | 25.2-31.1 | 60.4 | 22.0 | 19.6-24.6 | 18.6 | 3.5 | 2.9-4.3 | 11.2 | 4.5 | 3.4-5.8 | 7.4 | 2.7 | 1.9-3.7 |
55–59 years | 179.2 | 34.4 | 32.2-36.7 | 102.8 | 41.9 | 38.4-45.7 | 76.4 | 27.7 | 25.0-30.6 | 31.0 | 6.0 | 5.1-7.0 | 20.0 | 8.2 | 6.6-9.9 | 11.0 | 4.0 | 3.0-5.2 |
60–64 years | 220.4 | 46.5 | 43.8-49.3 | 117.2 | 53.8 | 49.5-58.3 | 103.2 | 40.3 | 36.9-44.0 | 35.8 | 7.6 | 6.5-8.7 | 23.4 | 10.7 | 8.9-12.9 | 12.4 | 4.8 | 3.7-6.2 |
65–69 years | 235.0 | 59.2 | 55.8-62.6 | 125.8 | 71.0 | 65.5-76.7 | 109.2 | 49.6 | 45.6-54.0 | 44.6 | 11.2 | 9.8-12.8 | 26.0 | 14.7 | 12.3-17.4 | 18.6 | 8.5 | 6.8-10.4 |
70–74 years | 234.4 | 76.8 | 72.5-81.3 | 115.8 | 88.6 | 81.6-96.1 | 118.6 | 67.9 | 62.6-73.6 | 47.2 | 15.5 | 13.6-17.6 | 26.8 | 20.5 | 17.2-24.3 | 20.4 | 11.7 | 9.5-14.2 |
75–79 years | 194.4 | 89.0 | 83.5-94.8 | 102.0 | 114.7 | 105.0-125.1 | 92.4 | 71.4 | 65.0-78.2 | 55.4 | 25.4 | 22.5-28.5 | 33.8 | 38.0 | 32.5-44.2 | 21.6 | 16.7 | 13.7-20.1 |
80–84 years | 157.4 | 101.7 | 94.7-109.0 | 80.0 | 132.6 | 119.9-146.2 | 77.4 | 81.9 | 74.0-90.5 | 54.6 | 35.3 | 31.2-39.7 | 27.0 | 44.7 | 37.5-53.0 | 27.6 | 29.2 | 24.5-34.5 |
85+ years | 155.8 | 88.2 | 82.1-94.6 | 69.0 | 116.7 | 104.7-129.7 | 86.8 | 73.9 | 67.1-81.1 | 89.4 | 50.6 | 46.0-55.5 | 38.8 | 65.6 | 56.7-75.5 | 50.6 | 43.1 | 37.9-48.7 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution.